Published in Medicine and Law Weekly, October 28th, 2005
Anders Johnsson, managing director at Aditus Medical explains: "There are several reasons why this patent is strategic for Aditus Medical. Apart from the method combining electroporation and radiotherapy, it also contains a strategic priority date and several electrode configurations useful for us and our customers."
"By this acquisition we prove our commitment to CythorLab and Intelligent Electroporation. We are now in a very strong position to begin licensing discussions around our technology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly